Short description: Elev transaminase/ldh. ICD-9-CM 790.4 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 790.4 should only be used for claims with a date of service on or before September 30, 2015.
Short description: Nonspec elev of levels of transamns & lactic acid dehydrgnse The 2021 edition of ICD-10-CM R74.0 became effective on October 1, 2020. This is the American ICD-10-CM version of R74.0 - other international versions of ICD-10 R74.0 may differ. The following code (s) above R74.0 contain annotation back-references
Long Description: Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] ICD-9 790.4 is a legacy non-billable code used to specify a medical diagnosis of nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh].
R74.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. Short description: Nonspec elev of levels of transamns & lactic acid dehydrgnse The 2021 edition of ICD-10-CM R74.0 became effective on October 1, 2020.
ICD-10 code R74. 01 for Elevation of levels of liver transaminase levels is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
R74. 0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] | ICD-10-CM.
R74. 0 is a VALID/BILLABLE ICD10 code, i.e it is valid for submission for HIPAA-covered transactions. R74. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Code R74. 0 Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH], has been expanded to separately report elevation of levels of liver transminase (R74. 01) and elevation of levels of LDH (R74. 02).
R94. 5 - Abnormal results of liver function studies | ICD-10-CM.
R740 - ICD 10 Diagnosis Code - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] - Market Size, Prevalence, Incidence, Quality Outcomes, Top Hospitals & Physicians.
Transaminitis, sometimes called hypertransaminasemia, refers to having high levels of certain liver enzymes called transaminases. When you have too many enzymes in your liver, they start to move into your blood stream.
Transaminitis, or hypertransaminasemia, refers to unusually high levels of a family of enzymes called transaminases. Transaminitis is not a disease, but it can point to other issues that require treatment. High levels of fat or similar problems may be causing inflammation in the liver.
5: Abnormal results of liver function studies.
ICD-10 code: R74. 8 Abnormal levels of other serum enzymes.
ICD-10 code Z13. 220 for Encounter for screening for lipoid disorders is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Elevation of levels of liver transaminase levels R74. 01 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R74. 01 became effective on October 1, 2021.
The 2022 edition of ICD-10-CM R74.0 became effective on October 1, 2021.
R74.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
R74.0 is a billable ICD code used to specify a diagnosis of nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH]. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
In medicine, the presence of elevated transaminases, commonly the transaminases alanine transaminase (ALT) and aspartate transaminase (AST), may be an indicator of liver damage. Other terms employed include transaminasemia and transaminitis, although some sources consider the latter pathologically meaningless. ...